A randomized, double-blind, placebo-controlled pilot study of sublingual versus oral immunotherapy for the treatment of peanut allergy
Open Access
- 18 December 2014
- journal article
- research article
- Published by Elsevier in Journal of Allergy and Clinical Immunology
- Vol. 135 (5), 1275-1282.e6
- https://doi.org/10.1016/j.jaci.2014.11.005
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Peanut allergy diagnoses among children residing in Olmsted County, MinnesotaJournal of Allergy and Clinical Immunology, 2012
- Oral Immunotherapy for Treatment of Egg Allergy in ChildrenNew England Journal of Medicine, 2012
- The natural history of persistent peanut allergyAnnals of Allergy, Asthma & Immunology, 2011
- The safety and efficacy of sublingual and oral immunotherapy for milk allergyJournal of Allergy and Clinical Immunology, 2011
- Sublingual immunotherapy for peanut allergy: Clinical and immunologic evidence of desensitizationJournal of Allergy and Clinical Immunology, 2011
- Epidemiology of food allergyJournal of Allergy and Clinical Immunology, 2011
- National prevalence and risk factors for food allergy and relationship to asthma: Results from the National Health and Nutrition Examination Survey 2005-2006Journal of Allergy and Clinical Immunology, 2010
- Oral peanut immunotherapy in children with peanut anaphylaxisJournal of Allergy and Clinical Immunology, 2010
- US prevalence of self-reported peanut, tree nut, and sesame allergy: 11-year follow-upJournal of Allergy and Clinical Immunology, 2010
- Adverse reactions during peanut oral immunotherapy home dosingJournal of Allergy and Clinical Immunology, 2009